In a case-control study conducted in a Caucasian population, rs2289591 in PER1 (OR = 1.25; 95%CI: 1.00–1.57) was associated with more aggressive prostate cancer risk under a dominant genetic model [45]. The gene discussed is PER1; the disease is prostate cancer.